Ketamine-Assisted Psychotherapy for Treatment of Co-occurring Borderline Personality Disorder and Depression: A Case Study.
Study Goal
The researchers aimed to explore the potential of ketamine-assisted psychotherapy (KAP) in treating a patient with co-occurring borderline personality disorder (BPD) and depression.
Results Summary
The case study reported positive outcomes, suggesting KAP may be beneficial for BPD and comorbid depression, warranting further systematic research.
Population
A patient with co-occurring BPD and depression.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
ketamine-assisted psychotherapy (KAP) | increase | treatment of BPD and depression | a patient with co-occurring BPD and depression | - | positive outcomes | #1 |
Borderline personality disorder (BPD) is a mental health condition characterized by a pervasive pattern of impulsivity, affective dysregulation, and cognitive-perceptual symptoms. Treatment of BPD remains a significant challenge to mental health clinicians. People who suffer from BPD frequently have comorbid psychiatric disorders, which makes treatment more complex. This case study describes a course of ketamine-assisted psychotherapy (KAP) to treat a patient with co-occurring BPD and depression. KAP uses the antidepressant and psychedelic effects of ketamine embedded in a psychotherapy format to utilize the concept of an inner healing intelligence within the patient and the intersubjective relationship between patient and therapist as therapeutic factors. The positive outcomes in this case study suggest that more systematic research is warranted in the use of KAP for treatment of BPD and other personality disorders.